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   Abstract  
Thymoquinone (TQ) is the major active compound in black seed oil (BSO). Many pharmacological effects of TQ, such
as anti-inflammatory, hypoglycemic, antioxidant, immune stimulator, and anticancer, have been reported. TQ can be
considered as a biomarker for BSO, but its content in the commercial products is rarely reported. TQ content varies based
on the oil source and extraction method. This study aimed to quantify the TQ content in the commercial BSO products in
Malaysia and to evaluate whether the products can be used as a source of TQ for therapeutic benefits. TQ was quantified
using an established high-performance liquid chromatography (HPLC) method. TQ human equivalent dose (HED) was
calculated based on reported animal studies from literature, and theoretical BSO amount containing the TQ dose was
calculated based on the HPLC analysis. TQ content in the commercial BSO products ranged from 0.07% wt/wt to 1.88%
wt/wt. The product with the highest TQ concentration is approximately 27-fold higher than the product with the lowest
TQ concentration. Consequently, theoretical BSO amounts needed for specific diseases varied and some products cannot
provide practical amount of TQ. This study recommends the regulation of TQ content in BSO and suggests that the BSO
might be fortified with extra TQ to be effectively used in some diseases.
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   Introduction  
Thymoquinone (TQ) is the main active compound in black seed oil (BSO, Nigella sativa oil or black cumin oil), which
constitutes approximately 30% of the seeds.[1] Many pharmacological effects of TQ, such as anti-inflammatory and
hypoglycemic, have been reported.[2],[3] Badary et al.[4] reported that the TQ can be used as an antioxidant. Many other
medical and pharmacological uses of TQ, such as immune stimulator and anticancer, have also been reported.[5],[6]
Recent studies have attempted to use the standardized N. sativa extract based on the quantification of TQ.[7],[8]
Therefore, TQ can be used as a biomarker for N. sativa oil.
BSO is used in folk medicine to treat several illnesses, such as cough, fever, diarrhea, and abdominal disorders, but only
a few clinical trials were conducted either on the oil or its purified compound, TQ.[9] Most of the research on N. sativa
was conducted on the purified TQ in animal models or in cultured cells. The amount of TQ in BSO was rarely reported,
and it is not regulated in the commercial BSO.[10],[11] In a recent study, Khonche et al.[8] used standardized N. sativa
seed fixed oil containing 0.987 ± 0.07 mg/mL of TQ to analyze hepatic steatosis, aminotransferase, and lipid levels in
nonalcoholic fatty liver disease. As BSO can be administered as a source of TQ, the TQ content should be known to use
it scientifically to treat some diseases. A phase I clinical trial on TQ found that TQ was well tolerated at a dose from 75
to 2600 mg/day with no toxicity to be reported.[12] Considering that TQ content in BSO is generally less than 2% as
stated in the reported studies, therefore no toxicity is expected from TQ in BSO when taken at the recommended doses.
[7],[8]
Therefore, this study aimed to quantify the TQ content in the commercial BSO available in Malaysia and to find the
amount of commercial BSO needed to obtain a specific amount of TQ.
   Materials and Methods  
Materials
TQ standard was purchased from Sigma-Aldrich (St. Louis, Missouri). Acetonitrile (high-performance liquid
chromatography [HPLC] grade) and methanol (HPLC grade) were purchased from Merck (Darmstadt, Germany). All
other chemicals were of analytical grade.
Samples
Commercially available BSO products were purchased from local markets and pharmacies in Peninsular Malaysia. The
products were selected to contain mainly BSO in capsules and liquid dosage form only (the commercially available forms
of BSO). The analysis was performed on the available products in the market, and 10 such products were selected.
Thymoquinone quantification
The HPLC method adopted from Salmani et al.[13] was used to quantify the TQ in BSO. Briefly, BSO sample (50 mg
directly from the liquid dosage form or from the capsule form to obtain the liquid BSO) was dissolved in 10 mL of
methanol to extract the TQ. After that, it was mixed well by inverting the tube 10 times, then centrifuged at 4000rpm at
room temperature for 5 min to separate the methanol layer. The upper methanol layer, well separated from the bottom
BSO, was collected and filtered using a 0.45-μm syringe filter. The HPLC analysis was applied using Shimadzu LC-
20AT equipment (Shimadzu, Kyoto, Japan). A mixture of acetonitrile and water in the ratio of 60:40 was used as a
mobile phase at a flow rate of 1 mL/min using Inspire C18 (4.6mm × 250mm, 5 µm) analytical column. The detection
was performed at an ultraviolet wavelength of 254nm using a diode-array detector.
Calculation of theoretical amount of black seed oil for selected diseases
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where HED stands for human equivalent dose, Animal Km is a constant value for each animal (mouse: 3, rat: 6), and
human Km is a constant value equates to 37.
According to the quantification results of TQ in the commercial BSO products, the theoretical amounts of the BSO
needed to provide the TQ amount for different diseases were calculated.
   Results  
HPLC analysis revealed well-separated peaks of TQ at retention time of approximately 6.1 min [Figure 1]. The method
showed linearity in the range 0.01–150 μg/mL with R2 = 0.9943.
Figure 1: Chromatogram of placebo, TQ standard, and one BSO sample. For placebo,
olive oil was used and it was processed exactly as BSO samples. BSO = black seed oil,
TQ = thymoquinone
Click here to view
Quantification of the percentage of TQ in the commercial BSO products revealed large differences as low as 0.07%
wt/wt up to 1.88% wt/wt as shown in [Table 1]. TQ percentage in BSO packed in bottles ranged from 0.14% to 1.88%,
whereas it ranged from 0.07% to 1.86% for capsule forms. The product with the highest TQ concentration is
approximately 27-folds higher than the product with the lowest TQ concentration.
Table 1: Thymoquinone concentration in commercial black seed oil products
Click here to view
TQ was used in different diseases for treatment or protection. Selected TQ animal studies are summarized in [Table 2].
The calculated TQ doses in HED varied widely from 4.8 mg/day for hypertension and renal damage to 780 mg/day for
diabetes mellitus. The amount of BSO required to provide the specific amount of TQ was further varied among different
products [Table 2]. For example, compared with the low BSO amount needed for hypertension and renal damage (0.26–
0.52g/day from P10), an extraordinarily large amount is needed for diabetes mellitus (277.71–555.42g/day from P9).
Table 2: Thymoquinone doses in different animal studies and the calculated human
equivalent dose per 60kg together with the theoretical black seed oil quantity needed
from different products (g/day) to provide the calculated thymoquinone quantity
Click here to view
   Discussion  
TQ percentage in BSO was not directly related to packaging of the products (capsule and liquid in bottle). A large
difference in the TQ content in the products could be attributed to the source of BSO as well as the extraction method.
Different studies on the BSO showed that TQ content varied considerably in oils from different origins. For example,
Houghto et al. reported 0.17% wt/vol TQ in the Ethiopian BSO, whereas Azad et al. reported 1.96% wt/wt (~2.06%
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wt/vol) TQ in BSO sourced from Malaysia and Bangladesh.[15],[16] In addition, the TQ content in BSO varied based on
the different extraction techniques. In one study, BSO was extracted from supercritical carbon dioxide and the TQ
contents varied in the range of 3.04–4.09 mg/g oil (0.30%–0.41%) based on the extraction parameters.[17] In another
study, six different batches of cold-pressed black cumin seed oils were prepared, and TQ content was found in the range
of 3.48–8.73 mg/g (0.35%–0.87%).[18]
The therapeutic effects of black seed and its oils or extracts were investigated in several studies but without quantification
of the TQ content. For example, Qidwai et al.[10] conducted a clinical trial using the powdered black seed in a capsule at
a dose of 1g twice daily (2g/day). However, there is a trend to use standardized black seed extracts in the more recent
studies. The standardization was based on the quantification of TQ.[7],[8] For example, a study investigated the efficacy
and safety of standardized BSO in the treatment of patients with nonalcoholic fatty liver disease. Therefore, TQ can be
used as a biomarker for N. sativa oil.
Since clinical studies of TQ or standardized BSO are lacking, we calcualted the human TQ doses based on available
animal studies. To obtain a specific dose of TQ from the commercial BSO products, we used the TQ analysis results for
calcualtion. This method of estimation has some limitations like the lack of bioavailability data to know how much from
the ingeted dose will reach the general circulation. The estimated BSO amount that contains theoretical therapeutic TQ
amount was found to be very large to be consumed. For example, at least 277.71g of the commercial product P9 is
needed for diabetes mellitus. Such BSO amount clearly seems to be very large and even exceeds the 27g/day
recommended daily intake of oils.[19] Considering the low percentage of TQ in BSO (usually <2%) and the high safety
margin of TQ (up to 2600 mg/day with no reported toxicity), consumption of large amount of BSO is expected not to
result in toxicity from TQ; however, effects of overconsumption of lipids may occur as BSO consists mainly of fatty
acids.[20]
   Conclusion  
Using BSO in the treatment of a specific disease needs a clinical trial to evaluate the safety and efficacy. However, due to
the lack of clinical trials using BSO, the data from TQ may be used as a starting guide. The patient may consider taking
an amount of BSO that has the required amount of TQ, with limitations such as lack of bioavailability data. Calculating
the BSO amount that contains specific TQ amount can only be accomplished by knowing the TQ content in the
commercial BSO, which is now not available and not regulated. As a result, commercial BSO products have large
variations in TQ content and some of them may not provide the TQ amount needed for some diseases. This study
recommends the regulation of TQ content in the commercial BSO. It also suggests that BSO could be fortified with
additional TQ to be beneficial in more diseases.
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